AVIRAtea Pharmaceuticals, Inc.vs its industry peers
A metric-by-metric comparison of Atea Pharmaceuticals, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AVIR본 종목 | $419M#8 | — | 2.1x#5 | 1.2x#1 | 622.5%#1 | 6.0%#4 | -51.5%#2 | -77.4%#9 | — | — | — | — |
| IRD | $483M#1 | — | — | 34.0x#5 | 29.1%#2 | 13.8%#2 | -271.9%#5 | — | — | — | 326.8%#1 | — |
| INDP | $482M#2 | — | 42.4x#13 | — | — | -38.8%#9 | — | -183.3%#12 | — | — | 57.4%#3 | — |
| PBYI | $478M#3 | 18.2x#2 | 3.5x#11 | 2.1x#2 | -0.9%#3 | 2.8%#5 | 16.3%#1 | 22.5%#1 | — | — | 99.8%#2 | — |
| RLMD | $475M#4 | — | 2.3x#7 | 92548.4x#8 | -35.4%#5 | — | -1152275.3%#8 | 0.0%#2 | — | — | — | — |
| ARCT | $450M#5 | — | 2.6x#8 | 5.5x#4 | -46.1%#6 | 18.7%#1 | -93.0%#3 | -38.3%#5 | -136.2%#2 | — | — | — |
| PRTA | $429M#6 | — | 1.5x#4 | 44.3x#7 | -92.8%#7 | -99.6%#12 | -2216.4%#7 | -85.1%#10 | — | — | — | — |
| SPRY | $421M#7 | — | 33.7x#12 | 5.0x#3 | -5.5%#4 | -2241.8%#15 | -212.9%#4 | -1369.1%#15 | -177.6%#3 | — | — | — |
| GTBP | $410M#9 | 1.7x#1 | 114.8x#14 | — | — | -115.4%#14 | — | -794.5%#14 | — | — | -54.8%#5 | 0.1%#1 |
| LRMR | $408M#10 | — | 3.2x#9 | — | — | -105.5%#13 | — | -130.1%#11 | -350.3%#4 | — | — | — |
| RZLT | $402M#11 | — | 3.4x#10 | — | — | -8.7%#6 | — | -63.7%#8 | -72.2%#1 | — | — | — |
| TTRX | $395M#12 | — | 575.0x#15 | — | — | -80.6%#11 | — | -465.0%#13 | — | — | — | — |
| BBOT | $391M#13 | — | 1.2x#3 | — | — | -80.5%#10 | — | -41.5%#6 | — | — | — | — |
| BNTC | $389M#14 | — | 2.2x#6 | — | -100.0%#8 | -20.1%#8 | — | -25.7%#4 | — | — | -17.9%#4 | — |
| BIOA | $375M#15 | — | 1.0x#1 | 41.7x#6 | — | -13.4%#7 | -1031.5%#6 | -21.5%#3 | — | — | — | — |
| RCKT | $375M#16 | — | 1.0x#2 | — | — | 13.8%#3 | — | -60.5%#7 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-15.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice